XML 111 R92.htm IDEA: XBRL DOCUMENT
v3.24.4

SUBSEQUENT EVENTS (Details Narrative) - USD ($) |  |  | 1 Months Ended | 9 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | ---
Nov. 06, 2024 | Mar. 21, 2024 | Jul. 30, 2024 | Jul. 19, 2024 | Jun. 27, 2024 | Jan. 23, 2024 | Sep. 30, 2024 | Sep. 30, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Apr. 22, 2024
Purchase price for the acquisition amounted |  |  |  |  |  | $ 637,080,000,000 |  |  |  |  |
Consideration share |  |  |  |  |  | 280,000 |  |  |  |  |
Fair value of shares |  |  |  |  |  | $ 319,200 |  |  |  |  |
Settelment amount |  |  |  |  |  | 317,880 |  |  |  |  |
Intangible asset |  |  |  |  |  | $ 637,080 |  |  |  |  |
Common stock share sold |  | 901,488 |  |  |  |  | 901,488 |  |  |  |
Gross proceeds from share sold |  | $ 648,893 |  |  |  |  | $ 649,039 | $ 9,950,037 | $ 10,000,017 | $ 35,275,573 |
Common stock, par value |  |  |  |  |  |  | $ 0.001 |  | $ 0.001 | $ 0.001 | $ 0.001
Bid price | the closing bid price of the Company’s common stock being at least $1.00 per share for ten consecutive business days |  |  |  |  |  |  |  |  |  |
Minimum bid price | $ 1.00 |  |  |  |  |  |  |  |  |  |
Deadline report |  |  | Nasdaq further extended the filing deadline through October 14, 2024 |  |  |  |  |  |  |  |
Closing bid of shares of common stock | $ 1.00 |  |  |  |  |  |  |  |  |  |
Notification Letter [Member] |  |  |  |  |  |  |  |  |  |  |
Bid price |  |  |  | closing bid price of $1.00 or greater per common share for ten consecutive business days from July 5, 2024 to July 18, 2024 |  |  |  |  |  |  |
Minimum bid price |  |  |  | $ 1.00 |  |  |  |  |  |  |
Placement Agent [Member] |  |  |  |  |  |  |  |  |  |  |
Fees and other commissions |  | 23,153 |  |  |  |  | $ 19,467 |  |  |  |
Net proceeds |  | $ 625,740 |  |  |  |  | $ 629,426 |  |  |  |
Pharmalink [Member] |  |  |  |  |  |  |  |  |  |  |
First purchase order |  |  |  |  | 130,000 |  |  |  |  |  |
First year purchase order |  |  |  |  | 500,000 |  |  |  |  |  |
Over year five purchase order |  |  |  |  | 3,000,000 |  |  |  |  |  |

X
- References No definition available. + Details
Name: | cosm_AfterYearFivePurchaseOrder
Namespace Prefix: | cosm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cosm_BidingPriceDescripion
Namespace Prefix: | cosm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cosm_ClosingBidOfSharesOfCommonStock
Namespace Prefix: | cosm_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cosm_DeadlineReportDescription
Namespace Prefix: | cosm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cosm_MinimumBidPricePerShare
Namespace Prefix: | cosm_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | cosm_PurchaseOrderShares
Namespace Prefix: | cosm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cosm_ShareConsideration
Namespace Prefix: | cosm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | cosm_YearOnePurchase
Namespace Prefix: | cosm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Purchase price of expected asset acquisition prior to consideration being transferred. Excludes business acquisition. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 15 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3 + Details
Name: | us-gaap_AssetAcquisitionPriceOfAcquisitionExpected
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of addition (reduction) to the amount at which an instrument classified in shareholders' equity could be incurred (settled) in a current transaction between willing parties. + References No definition available. + Details
Name: | us-gaap_EquityFairValueAdjustment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount awarded from other party in judgment or settlement of litigation. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementAmountAwardedFromOtherParty
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other. + References No definition available. + Details
Name: | us-gaap_OtherIntangibleAssetsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash inflow from debt classified as other. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromOtherDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_SalesCommissionsAndFees
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of shares of stock issued attributable to transactions classified as other. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesOther
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_DebtInstrumentAxis=cosm_NotificationLetterMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=cosm_PlacementAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=cosm_PharmalinkMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |